52 Publications (Page 1 of 3)
2020
Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development.Konig, Heiko and Zeidner, JoshuaJuly 14, 2020
A Multi‐institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High‐Dose Cytarabine and Mitoxantrone (Ara‐C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid LeukemiaChristian, Sonia⋅Arain, Saad⋅Patel, Pritesh⋅Khan, Irum⋅Calip, Gregory S⋅Agrawal, Vaibhav⋅Sweiss, Karen⋅Griffin, Shawn⋅Cahill, Kirk⋅Konig, Heiko⋅Esen, Aysenur⋅Shergill, Ardaman⋅Odenike, Olatoyosi⋅Stock, Wendy and Quigley, John GAmerican Journal of Hematology, 2020-04-20.
| Journal Article
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemiaChristian, Sonia⋅Christian, Sonia⋅Arain, Saad⋅Arain, Saad⋅Patel, Pritesh⋅Patel, Pritesh⋅Khan, Irum⋅Khan, Irum⋅Calip, Gregory S⋅Calip, Gregory S⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Sweiss, Karen⋅Sweiss, Karen⋅Griffin, Shawn⋅Griffin, Shawn⋅Cahill, Kirk⋅Cahill, Kirk⋅Konig, Heiko⋅Konig, Heiko⋅Esen, Aysenur⋅Esen, Aysenur⋅Shergill, Ardaman⋅Shergill, Ardaman⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Stock, Wendy⋅Stock, Wendy⋅Quigley, John G and Quigley, John GAmerican journal of hematology, 2020-Apr-20.
| Journal Article
Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications.Chen, Fangli⋅Chen, Fangli⋅Chen, Fangli⋅Wu, Xue⋅Wu, Xue⋅Wu, Xue⋅Niculite, Cristina⋅Niculite, Cristina⋅Niculite, Cristina⋅Gilca, Marilena⋅Gilca, Marilena⋅Gilca, Marilena⋅Petrusca, Daniela⋅Petrusca, Daniela⋅Petrusca, Daniela⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rice, Susan⋅Rice, Susan⋅Rice, Susan⋅Guo, Bin⋅Guo, Bin⋅Guo, Bin⋅Griffin, Shawn⋅Griffin, Shawn⋅Griffin, Shawn⋅Calin, George A⋅Calin, George A⋅Calin, George A⋅Boswell, H Scott⋅Boswell, H Scott⋅Boswell, H Scott⋅Konig, Heiko⋅Konig, Heiko and Konig, HeikoJournal of cellular and molecular medicine, May 25, 2020.
| Journal Article
Management of fever and neutropenia in the adult patient with acute myeloid leukemia.Peseski, Andrew M⋅McClean, Mitchell⋅Green, Steven D⋅Beeler, Cole and Konig, HeikoExpert review of anti-infective therapy, pp. 1-20, October 5, 2020.
| Journal Article
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international studyStahl, Maximilian⋅⋅⋅⋅⋅Shallis, Rory M⋅Wei, Wei⋅Wei, Wei⋅Wei, Wei⋅Wei, Wei⋅Wei, Wei⋅⋅⋅⋅Montesinos, Pau⋅⋅Lengline, Etienne⋅Neukirchen, Judith⋅Neukirchen, Judith⋅Neukirchen, Judith⋅Neukirchen, Judith⋅Neukirchen, Judith⋅Bhatt, Vijaya R⋅Bhatt, Vijaya R⋅Bhatt, Vijaya R⋅Bhatt, Vijaya R⋅Bhatt, Vijaya R⋅Sekeres, Mikkael A⋅Sekeres, Mikkael A⋅Sekeres, Mikkael A⋅Sekeres, Mikkael A⋅Sekeres, Mikkael A⋅Fathi, Amir T⋅Fathi, Amir T⋅Fathi, Amir T⋅Fathi, Amir T⋅Fathi, Amir T⋅Konig, Heiko⋅⋅Luger, Selina⋅⋅⋅⋅Khan, Irum⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Cluzeau, Thomas⋅Cluzeau, Thomas⋅Cluzeau, Thomas⋅Cluzeau, Thomas⋅Cluzeau, Thomas⋅Martínez-Cuadron, David⋅Martínez-Cuadron, David⋅Martínez-Cuadron, David⋅Martínez-Cuadron, David⋅Martínez-Cuadron, David⋅Raffoux, Emmanuel⋅Germing, Ulrich⋅Manikkam, Umakanthan J⋅Umakanthan, Jayadev Manikkam⋅Manikkam, Umakanthan J⋅Manikkam, Umakanthan J⋅Manikkam, Umakanthan J⋅Mukherjee, Sudipto⋅Brunner, Andrew M⋅Brunner, Andrew M⋅Brunner, Andrew M⋅Brunner, Andrew M⋅Brunner, Andrew M⋅Miller, Adam⋅Miller, Adam⋅Miller, Adam⋅Miller, Adam⋅Miller, Adam⋅McMahon, Christine M⋅McMahon, Christine M⋅McMahon, Christine M⋅McMahon, Christine M⋅McMahon, Christine M⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Rodríguez-Veiga, Rebeca⋅⋅⋅⋅Itzykson, Raphaël⋅⋅Boluda, Blanca⋅Rabian, Florence⋅Tormo, Mar⋅Acuña-Cruz, Evelyn⋅Acuña-Cruz, Evelyn⋅Acuña-Cruz, Evelyn⋅Acuña-Cruz, Evelyn⋅Acuña-Cruz, Evelyn⋅Rabinovich, Emma⋅Rabinovich, Emma⋅Rabinovich, Emma⋅Rabinovich, Emma⋅Rabinovich, Emma⋅Yoo, Brendan⋅Yoo, Brendan⋅Yoo, Brendan⋅Yoo, Brendan⋅Yoo, Brendan⋅Cano, Isabel⋅Cano, Isabel⋅Cano, Isabel⋅Cano, Isabel⋅Cano, Isabel⋅Podoltsev, Nikolai A⋅Podoltsev, Nikolai A⋅Podoltsev, Nikolai A⋅Podoltsev, Nikolai A⋅Podoltsev, Nikolai A⋅Bewersdorf, Jan P⋅Bewersdorf, Jan P⋅Bewersdorf, Jan P⋅Bewersdorf, Jan Philipp⋅Bewersdorf, Jan P⋅Gore, Steven⋅Gore, Steven⋅Gore, Steven⋅Gore, Steven⋅Gore, Steven⋅Zeidan, Amer M⋅Zeidan, Amer M⋅Zeidan, Amer M⋅Zeidan, Amer M and Zeidan, Amer MLeukemia, 2020-Mar-04.
| Journal Article
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapyShallis, Rory M⋅Stahl, Maximilian⋅Wei, Wei⋅Montesinos, Pau⋅Lengline, Etienne⋅Neukirchen, Judith⋅Bhatt, Vijaya R⋅Sekeres, Mikkael A⋅Fathi, Amir T⋅Konig, Heiko⋅Luger, Selina⋅Khan, Irum⋅Roboz, Gail J⋅Cluzeau, Thomas⋅Martínez-Cuadron, David⋅Raffoux, Emmanuel⋅Germing, Ulrich⋅Umakanthan, Jayadev Manikkam⋅Mukhereje, Sudipto⋅Brunner, Andrew M⋅Miller, Adam⋅McMahon, Christine M⋅Ritchie, Ellen K⋅Rodríguez-Veiga, Rebeca⋅Itzykson, Raphaël⋅Boluda, Blanca⋅Rabian, Florence⋅Tormo, Mar⋅Acuña-Cruz, Evelyn⋅Rabinovich, Emma⋅Yoo, Brendan⋅Cano, Isabel⋅Podoltsev, Nikolai A⋅Bewersdorf, Jan Philipp⋅Gore, Steven and Zeidan, Amer MLeukemia & Lymphoma, vol. 61, (no. 5), pp. 1225, 4/15/2020.
| Journal Article
Vaccine and Cell Based Therapeutic Approaches in Acute Myeloid LeukemiaAgrawal, Vaibhav⋅Agrawal, Vaibhav⋅Gbolahan, Olumide B⋅Gbolahan, Olumide B⋅Stahl, Maximilian⋅Stahl, Maximilian⋅Zeidan, Amer M⋅Zeidan, Amer M⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Farag, Sherif S⋅Farag, Sherif S⋅Konig, Heiko and Konig, HeikoCurrent Cancer Drug Targets, vol. 20, 2020-05-02.
| Journal Article
2019
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trialsSayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Saliba, Antoine N⋅Saliba, Antoine N⋅Saliba, Antoine N⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Boswell, H. Scott⋅Boswell, H. Scott and Boswell, H. ScottLeukemia Research, vol. 77, pp. 33, February 2019.
| Journal Article
Cooperativity between Flt3/Syk and Proteasome Inhibitors in Flt3mutant/Wildtype AML, By Acting on the Oxphos and Wnt Endpoints of Syk and p62SQSTM1 Pathways Prohibits Protective Autophagy; While Downregulation of NRF2, NQO1, Jun, and b-Catenin Bypasses Interfering RAS or WT1 Co-MutationsRangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott and Boswell, H. ScottBlood, vol. 134, (no. Supplement_1), pp. 5051, 2019-11-13.
| Journal Article
Stabilization of enzyme-immobilized hydrogels for extended hypoxic cell cultureHudson, Britney⋅Hudson, Britney⋅Dawes, Camron⋅Dawes, Camron⋅Liu, Hung-Yi⋅Liu, Hung-Yi⋅DImmitt, Nathan⋅DImmitt, Nathan⋅Chen, Fangli⋅Chen, Fangli⋅Konig, Heiko⋅Konig, Heiko⋅Lin, Chien Chi and Lin, Chien-ChiEmergent Materials, vol. 2, (no. 2), pp. 272, 20190601.
| Journal Article
2018
Abstract 2427: Targeting intracellular pH regulation as a novel approach to overcome hypoxia-mediated drug resistance in FLT3/ITD mutated AMLChen, Fangli⋅Chen, Fangli⋅Chen, Fangli⋅Rogozea, Adriana L⋅Rogozea, Adriana L⋅Rogozea, Adriana L⋅Wu, Xue⋅Wu, Xue⋅Wu, Xue⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Konig, Heiko⋅Konig, Heiko and Konig, HeikoCancer Research, vol. 78, (no. 13 Supplement), pp. 2427, 2018-07-01.
| Journal Article
A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid LeukemiaChristian, Sonia⋅Patel, Pritesh⋅Agrawal, Vaibhav⋅Griffin, Shawn⋅Cahill, Kirk⋅Khan, Irum⋅Sweiss, Karen⋅Shergill, Ardaman⋅Calip, Gregory Sampang⋅Stock, Wendy⋅Odenike, Olatoyosi⋅Konig, Heiko and Quigley, John GBlood, vol. 132, (no. Supplement 1), pp. 1397, 2018-11-29.
| Journal Article
A multi-institution comparison of mitoxantrone, etoposide, and cytarabine (MEC) vs. high-dose cytarabine and mitoxantrone (Ara-C Couplets) therapy for patients with relapsed or refractory (R/R) acute myeloid leukemiaChristian, Sonia⋅Patel, Pritesh Rajni⋅Griffin, Shawn⋅Agrawal, Vaibhav⋅Khan, Irum⋅Sweiss, Karen⋅Shergill, Ardaman⋅Konig, Heiko and Quigley, John GJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e19005, 2018-05-20.
| Journal Article
A Single Institution Comparison of Treatment Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML) Treated in Pediatric and Adult SettingsAgrawal, Vaibhav⋅Agrawal, Vaibhav⋅Griffin, Jordyn⋅Griffin, Jordyn⋅O'Brien, Andrew⋅O'Brien, Andrew⋅Nelson, Robert P⋅Nelson, Robert P⋅Skiles, Jodi L⋅Skiles, Jodi L⋅Konig, Heiko and Konig, HeikoBlood, vol. 132, (no. Supplement 1), pp. 5859, 2018-11-29.
| Journal Article
Characteristics, Treatment Patterns and Outcomes Among Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Hyperleukocytosis: Findings from a Large International Patient CohortStahl, Maximilian⋅Wei, Wei⋅Montesinos, Pau⋅Lengline, Etienne⋅Shallis, Rory M⋅Neukirchen, Judith⋅Bhatt, Vijaya R⋅Sekeres, Mikkael A⋅Fathi, Amir T⋅Konig, Heiko⋅Luger, Selina⋅Khan, Irum⋅Roboz, Gail J⋅Cluzeau, Thomas⋅Martínez-Cuadron, David⋅Raffoux, Emmanuel⋅Germing, Ulrich⋅Manikkam Umakanthan, Jayadev⋅Mukherjee, Sudipto⋅Brunner, Andrew M⋅Miller, Adam M⋅McMahon, Christine M⋅Ritchie, Ellen K⋅Rodríguez-Veiga, Rebeca⋅Itzykson, Raphael⋅Boluda, Blanca⋅Rabian, Florence⋅Tormo, Mar⋅Acuna Cruz, Evelyn Gloria⋅Rabinovich, Emma⋅Yoo, Brendan⋅Podoltsev, Nikolai A⋅Gore, Steven D and Zeidan, Amer MBlood, vol. 132, (no. Supplement 1), pp. 4040, 2018-11-29.
| Journal Article
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trialsSayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Saliba, Antoine N⋅Saliba, Antoine N⋅Saliba, Antoine N⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Boswell, H Scott⋅Boswell, H Scott and Boswell, H ScottLeukemia research, vol. 77, pp. 30, 2018-Dec-24.
| Journal Article
Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AMLSayar, Hamid⋅Sayar, Hamid⋅Sayar, H.⋅Sayar, Hamid⋅Sayar, Hamid⋅Liu, Yan⋅Liu, Yan⋅Liu, Y.⋅Liu, Yan⋅Liu, Yan⋅Gao, R.⋅Gao, Rui⋅Gao, Rui⋅Gao, Rui⋅Gao, Rui⋅Zaid, Mohammad Abu⋅Zaid, M.A.⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, L.D.⋅Cripe, Larry D⋅Weisenbach, Jill⋅Weisenbach, Jill⋅Weisenbach, J.⋅Weisenbach, Jill⋅Weisenbach, Jill⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, K.J.⋅Sargent, Katie J⋅Sargent, Katie J⋅Nassiri, Mehdi⋅Nassiri, M.⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Li, Lang⋅Li, Lang⋅Li, Lang⋅Li, Lang⋅Li, L.⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, H.⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, A.⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Pan, Feng⋅Pan, Feng⋅Pan, Feng⋅Pan, Feng⋅Pan, F.⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, R.⋅Shanmugam, Rajasubramaniam⋅Goswami, Chirayu⋅Goswami, Chirayu⋅Goswami, Chirayu⋅Goswami, C.⋅Goswami, Chirayu⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, R.⋅Kapur, Reuben⋅Xu, Mingjiang⋅Xu, Mingjiang⋅Xu, Mingjiang⋅Xu, M.⋅Xu, Mingjiang⋅Scott Boswell, H.⋅Boswell, H Scott⋅Boswell, H Scott⋅Boswell, H Scott and Boswell, H ScottOncotarget, vol. 9, (no. 5), pp. 5715, 2018-Jan-19.
| Journal Article
Genoproteomic analysis of leukemic cell response to Cytarabine reveals synergistic opportunities centered on cholesterol metabolismFarmer, Alex⋅Farmer, Alex⋅Chen, Fangli⋅Chen, Fangli⋅Wu, Xue⋅Wu, Xue⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Ivan, Mircea⋅Ivan, Mircea⋅Konig, Heiko and Konig, HeikoProceedings of IMPRS, vol. 1, (no. 1), 2018-12-07.
| Journal Article
Identification of Beta-Catenin As a Novel Ubiquitin-Regulated Target of Combined Flβ3/Syk- and Proteasome Inhibitors for Interruption of LSC Signaling in Poor-Risk AMLRangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Rangaraju, Sravanti⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Marino, Silvia⋅Petrusca, Daniela Nicoleta⋅Petrusca, Daniela Nicoleta⋅Petrusca, Daniela Nicoleta⋅Petrusca, Daniela Nicoleta⋅Petrusca, Daniela Nicoleta⋅Petrusca, Daniela Nicoleta⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Sargent, Katie J⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Roodman, G. David⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Ramdas, Baskar⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Palam, Lakshmi Reddy⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Rogozea, Adriana⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Konig, Heiko⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Kapur, Reuben⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott and Boswell, H. ScottBlood, vol. 132, (no. Supplement 1), pp. 3949, 2018-11-29.
| Journal Article
Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient CohortStahl, Maximilian⋅Wei, Wei⋅Montesinos, Pau⋅Lengline, Etienne⋅Shallis, Rory M⋅Neukirchen, Judith⋅Bhatt, Vijaya R⋅Sekeres, Mikkael A⋅Fathi, Amir T⋅Konig, Heiko⋅Luger, Selina⋅Khan, Irum⋅Roboz, Gail J⋅Cluzeau, Thomas⋅Martínez-Cuadron, David⋅Raffoux, Emmanuel⋅Germing, Ulrich⋅Manikkam Umakanthan, Jayadev⋅Mukherjee, Sudipto⋅Brunner, Andrew M⋅Miller, Adam M⋅McMahon, Christine M⋅Ritchie, Ellen K⋅Rodríguez-Veiga, Rebeca⋅Itzykson, Raphael⋅Boluda, Blanca⋅Rabian, Florence⋅Tormo, Mar⋅Acuna Cruz, Evelyn Gloria⋅Rabinovich, Emma⋅Yoo, Brendan⋅Podoltsev, Nikolai A⋅Gore, Steven D and Zeidan, Amer MBlood, vol. 132, (no. Supplement 1), pp. 1428, 2018-11-29.
| Journal Article
Integrative Analysis of AML Cell Response to Cytarabine Reveals Synergistic Opportunities Centered on Cholesterol MetabolismChen, Fangli⋅Chen, Fangli⋅Wu, Xue⋅Wu, Xue⋅Adriana, Rogozea⋅Adriana, Rogozea⋅Guo, Bin⋅Guo, Bin⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Calin, George A⋅Calin, George A⋅Ivan, Mircea⋅Ivan, Mircea⋅Konig, Heiko and Konig, HeikoBlood, vol. 132, (no. Supplement 1), pp. 2631, 2018-11-29.
| Journal Article
Outcomes of Patients with Newly-Diagnosed Acute Myeloid Leukemia and Hyperleukocytosis Who Did Not Undergo Intensive Chemotherapy: Results from a Large International DatabaseShallis, Rory M⋅Stahl, Maximilian⋅Wei, Wei⋅Montesinos, Pau⋅Lengline, Etienne⋅Neukirchen, Judith⋅Bhatt, Vijaya R⋅Sekeres, Mikkael A⋅Fathi, Amir T⋅Konig, Heiko⋅Luger, Selina⋅Khan, Irum⋅Roboz, Gail J⋅Cluzeau, Thomas⋅Martínez-Cuadron, David⋅Raffoux, Emmanuel⋅Germing, Ulrich⋅Manikkam Umakanthan, Jayadev⋅Mukherjee, Sudipto⋅Brunner, Andrew M⋅Miller, Adam M⋅McMahon, Christine M⋅Ritchie, Ellen K⋅Rodríguez-Veiga, Rebeca⋅Itzykson, Raphael⋅Boluda, Blanca⋅Rabian, Florence⋅Tormo, Mar⋅Acuna Cruz, Evelyn Gloria⋅Podoltsev, Nikolai⋅Gore, Steven D and Zeidan, Amer MBlood, vol. 132, (no. Supplement 1), pp. 3999, 2018-11-29.
| Journal Article
The rocky road to personalized medicine in acute myeloid leukaemiaBrinda, Bryan⋅Khan, Irum⋅Parkin, Brian and Konig, HeikoJournal of Cellular and Molecular Medicine, vol. 22, (no. 3), pp. 1427, March 2018.
| Journal Article
2017
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AMLKnapper, Steven⋅Russell, Nigel⋅Gilkes, Amanda⋅Hills, Robert K⋅Gale, Rosemary E⋅Cavenagh, James D⋅Jones, Gail⋅Kjeldsen, Lars⋅Grunwald, Michael R⋅Thomas, Ian⋅Konig, Heiko⋅Levis, Mark J and Burnett, Alan KBlood, vol. 129, (no. 9), pp. 1154, 2017-03-02.
| Journal Article
